CXCL6 and cancer: CXCL6 was identified as a potential predictive biomarker for hepatocellular carcinoma patients undergoing trans arterial chemoembolization in Kinzler et al. (2023); CXCL6 is an inflammatory chemokine that plays a crucial role in immune response and cancer progression.